ROSEN Law Firm Encourages Boston Scientific Investors to Secure Counsel Before Deadline

Investors who purchased Boston Scientific stock between July 2025 and February 2026 may be eligible for compensation.

Apr. 18, 2026 at 8:48pm

Got story updates? Submit your updates here. ›

A photorealistic studio still life featuring a stack of financial documents, a calculator, and a gavel on a clean, monochromatic background, symbolizing the abstract concepts of corporate finance, legal proceedings, and investor rights.A minimalist still life captures the gravity of a securities class action lawsuit against a major medical device company.NYC Today

The Rosen Law Firm, a global investor rights law firm, is reminding purchasers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026 of the important May 4, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Boston Scientific made positive statements to investors while disseminating materially false and misleading information about the true state of its U.S. Electrophysiology segment.

Why it matters

This case highlights the importance of investors being aware of potential securities fraud and taking action to protect their rights. The Rosen Law Firm has a track record of success in securities class actions and is encouraging investors to select qualified counsel to represent them.

The details

According to the lawsuit, Boston Scientific's management was aware that the growth rate of its U.S. Electrophysiology segment was unsustainable and approaching an earlier tipping point than the market anticipated. However, the company made positive statements to investors, leading them to be surprised when Boston Scientific missed its net income target and provided underwhelming guidance for the first half of fiscal 2026.

  • The Class Period is from July 23, 2025 to February 3, 2026.
  • The lead plaintiff deadline is May 4, 2026.

The players

The Rosen Law Firm, P.A.

A global investor rights law firm that represents investors throughout the world, concentrating its practice in securities class actions and shareholder derivative litigation.

Boston Scientific Corporation

A medical device company that manufactures and markets medical devices for use in various interventional medical specialties.

Got photos? Submit your photos here. ›

What they’re saying

“Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar.”

— Laurence Rosen, Founding Partner, Rosen Law Firm

What’s next

Investors who purchased Boston Scientific stock during the Class Period have until May 4, 2026 to move the Court to serve as lead plaintiff in the securities class action lawsuit.

The takeaway

This case highlights the importance of investors being vigilant and taking action to protect their rights when they suspect securities fraud. The Rosen Law Firm's track record of success in securities class actions makes them a qualified choice for investors seeking representation.